Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.

Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC.

J Infect Dis. 2013 Dec 1;208(11):1776-83. doi: 10.1093/infdis/jit357. Epub 2013 Jul 30.

2.

Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.

Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, Grunfeld C, Rosenberg WM, Peters MG, Tien PC.

J Infect Dis. 2016 Apr 1;213(7):1079-86. doi: 10.1093/infdis/jiv567. Epub 2015 Nov 29.

3.

Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.

Shah S, Ma Y, Scherzer R, Huhn G, French AL, Plankey M, Peters MG, Grunfeld C, Tien PC.

AIDS. 2015 Jul 17;29(11):1325-33. doi: 10.1097/QAD.0000000000000654.

4.

Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore RD, Afdhal N, Torbenson M, Sulkowski M, Thomas DL.

Clin Infect Dis. 2009 Apr 1;48(7):963-72. doi: 10.1086/597350.

5.

Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.

Gonzalez FA, Van den Eynde E, Perez-Hoyos S, Navarro J, Curran A, Burgos J, Falcó V, Ocaña I, Ribera E, Crespo M.

HIV Med. 2015 Apr;16(4):211-8. doi: 10.1111/hiv.12197. Epub 2014 Sep 18.

6.

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.

Merchante N, Rivero-Juárez A, Téllez F, Merino D, José Ríos-Villegas M, Márquez-Solero M, Omar M, Macías J, Camacho A, Pérez-Pérez M, Gómez-Mateos J, Rivero A, Antonio Pineda J; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

Hepatology. 2012 Jul;56(1):228-38. doi: 10.1002/hep.25616. Epub 2012 Jun 6.

PMID:
22278746
7.

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team.

J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.

PMID:
24730732
8.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
9.

Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.

Sánchez-Conde M, Montes Ramírez ML, Bellón Cano JM, Caminoa A, Alvarez Rodríguez F, González Garcia J, Miralles Martín P, Bernardino de la Serna I, Bernardo de Quirós JC, Arribas López JR, Cosín Ochaíta J, Pascual Pareja JF, Alvarez E, Berenguer JB.

J Viral Hepat. 2011 Jul;18(7):e278-83. doi: 10.1111/j.1365-2893.2010.01407.x. Epub 2010 Dec 3.

PMID:
21129129
10.

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, Ríos MJ, García-García JA, Camacho A, López-Cortés L, Ruiz J, de la Torre J, Viciana P, Pineda JA; Grupo para el Estudio de las Hepatitis Viricas de la SAEI.

Clin Infect Dis. 2007 Oct 15;45(8):969-74. Epub 2007 Sep 11.

PMID:
17879910
11.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772
12.

Use of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysis.

Njei B, McCarty TR, Luk J, Ewelukwa O, Ditah I, Lim JK.

J Gastroenterol Hepatol. 2016 Oct;31(10):1684-1693. doi: 10.1111/jgh.13337. Review.

13.

Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.

Li Vecchi V, Soresi M, Colomba C, Mazzola G, Colletti P, Mineo M, Di Carlo P, La Spada E, Vizzini G, Montalto G.

World J Gastroenterol. 2010 Nov 7;16(41):5225-32.

14.

Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.

Merchante N, Rivero A, de Los Santos-Gil I, Merino D, Márquez M, López-Ruz MA, Rodríguez-Baño J, Del Valle J, Camacho A, Sanz-Sanz J, Macías J, Pérez-Camacho I, Gómez-Mateos J, Moro A, Pineda JA.

Gut. 2009 Dec;58(12):1654-60. doi: 10.1136/gut.2009.179085. Epub 2009 Jul 21.

PMID:
19625279
15.

Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.

Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G.

Med Mal Infect. 2013 Jun;43(6):222-5. doi: 10.1016/j.medmal.2013.02.011. Epub 2013 Apr 15.

PMID:
23597924
16.

Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.

Sacchi P, Cima S, Corbella M, Comolli G, Chiesa A, Baldanti F, Klersy C, Novati S, Mulatto P, Mariconti M, Bazzocchi C, Puoti M, Pagani L, Filice G, Bruno R.

Dig Liver Dis. 2015 Mar;47(3):218-25. doi: 10.1016/j.dld.2014.11.012. Epub 2014 Nov 29.

PMID:
25544657
17.

Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.

Li Vecchi V, Giannitrapani L, Di Carlo P, Mazzola G, Colletti P, La Spada E, Vizzini G, Montalto G, Soresi M.

Ann Hepatol. 2013 Sep-Oct;12(5):740-8.

18.

Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Bierhoff E, Fischer HP, Willsch E, Rockstroh J, Spengler U, Brackmann HH, Oldenburg J.

Virchows Arch. 1997 Apr;430(4):271-7.

PMID:
9134037
19.

Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.

Williams SK, Donaldson E, Van der Kleij T, Dixon L, Fisher M, Tibble J, Gilleece Y, Klenerman P, Banham AH, Howard M, Webster DP.

J Viral Hepat. 2014 Apr;21(4):251-9. doi: 10.1111/jvh.12141. Epub 2013 Aug 15.

20.

Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.

Hodowanec AC, Brady KE, Gao W, Kincaid SL, Plants J, Bahk M, Landay AL, Huhn GD.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):232-40. doi: 10.1097/QAI.0b013e31829c6de0.

PMID:
24131865

Supplemental Content

Support Center